Almanac 2013: acute coronary syndromes
Pascal Meier1, Alexandra J Lansky, Andreas Baumbach
1Division of Cardiology, Yale Medical School, New Haven, CT, USA, pascalmeier74@gmail.com.
Unstable coronary artery plaque causes acute coronary syndromes (ACS). Recent advances in novel antiplatelet agents like prasugrel, ticagrelor, and cangrelor are improving outcomes and reducing mortality from severe ACS events.
Area of Science:
- Cardiology
- Vascular Biology
Background:
- Unstable coronary artery plaque is the primary cause of acute coronary syndromes (ACS).
- ACS encompasses conditions like unstable angina, non-ST segment elevation myocardial infarction (NSTE-ACS), and ST-elevation myocardial infarction (STEMI).
- Ischemia-induced tachyarrhythmias can lead to sudden cardiac arrest, a severe manifestation of ACS.
Purpose of the Study:
- To review the underlying causes of acute coronary syndromes.
- To highlight recent therapeutic advancements in managing ACS.
- To discuss the impact of novel antiplatelet agents on ACS mortality.
Main Methods:
- Literature review of recent studies on acute coronary syndromes.
- Analysis of therapeutic progress in antiplatelet therapy.
- Examination of mortality trends in ACS, STEMI, and cardiac arrest.
Main Results:
- Significant decrease in ACS mortality observed in recent years.
- Mortality reduction is particularly notable for severe ACS manifestations like STEMI and cardiac arrest.
- Novel antiplatelet agents show promise in further improving ACS outcomes.
Conclusions:
- Unstable plaque rupture remains a critical issue in cardiovascular disease.
- Therapeutic progress, especially with new antiplatelet drugs, is significantly improving ACS patient survival.
- Continued research and adoption of novel therapies are expected to further reduce ACS-related mortality.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Introduction Cardiac Emergencies
